CollPlant Biotechnologies
CLGN
4 hedge funds and large institutions have $2.5M invested in CollPlant Biotechnologies in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
250,200% more capital invested
Capital invested by funds: $1K → $2.5M (+$2.5M)
300% more funds holding
Funds holding: 1 → 4 (+3)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
5.02% more ownership
Funds ownership: 0% → 5.02% (+5%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IMOV
Investment Management of Virginia
Richmond,
Virginia
|
+$1.62M |
| 2 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$1.12M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$35.4K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$8.58K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IMOV
1
Investment Management of Virginia
Richmond,
Virginia
| $1.46M | +$1.62M | +158,116 | New |
|
|
MIH
2
Meitav Investment House
Bene-Beraq,
Israel
| $1.01M | +$1.12M | +109,541 | New |
|
|
3
Acadian Asset Management
Boston,
Massachusetts
| $32K | +$35.4K | +3,446 | New |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $8K | +$8.58K | +836 | New |
|
|
HIIFS
5
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
| – | -$1K | -106 | Closed |
|
CLGN Hedge Fund Activity: Q1 2020 in Review
4 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q1 2020, worth a combined $2.5M — up 250,200% from $1K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CLGN positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Investment Management of Virginia, opening a new position worth an estimated $1.62M. The largest seller was Harel Insurance Investments & Financial Services, exiting entirely with an estimated $1K sold.
- 4 institutional investors held CollPlant Biotechnologies (CLGN) as of Q1 2020, up from 1 in Q4 2019.
- Funds reported $2.5M of CollPlant Biotechnologies stock for Q1 2020, up 250,200% quarter-over-quarter.
- 4 funds opened new CollPlant Biotechnologies positions in Q1 2020 and 1 closed out, a net change of +3 holders.
- The largest CollPlant Biotechnologies buyer in Q1 2020 was Investment Management of Virginia, an estimated $1.62M added.
- The largest CollPlant Biotechnologies seller in Q1 2020 was Harel Insurance Investments & Financial Services, an estimated $1K sold.
Based on aggregated 13F filings for Q1 2020.